REAl-world Outcomes in CHronic Lymphocytic Leukemia Patients Receiving Acalabrutinib in Romania
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Clinical Trials Related to AstraZeneca
Related studies linked through entity extraction aliases.
Anticoagulant-associated Intracranial Hemorrhage
- Status
- RECRUITING
- Phase
- N/A
A Study to Investigate the Effect of Baxdrostat on Ambulatory Blood Pressure in Participants With Resistant Hypertension
- Status
- COMPLETED
- Phase
- PHASE3
A Longitudinal Multi-Omic Biomarker Profiling Study of Patients With Head & Neck Squamous Cell Carcinoma (HNSCC)
- Status
- RECRUITING
- Phase
- N/A
An ADME Study of [14C]AZD4604 and the Absolute Bioavailability of AZD4604
- Status
- COMPLETED
- Phase
- PHASE1
An Observational Study to Describe EVUSHELD™ (Tixagevimab/Cilgavimab) Pre-exposure Prophylaxis in Real-world Setting in Japan
- Status
- COMPLETED
- Phase
- N/A
A Real-world, Multi-center, Prospective, Observational Study for PNH in China
- Status
- COMPLETED
- Phase
- N/A
A Trial to Learn How Safe AZD9550 Monotherapy and Combined With AZD6234 is in People With or Without Type 2 Diabetes Who Are Living With Obesity and Overweight
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Study to Describe the Characteristics, Health Care Interventions and Outcomes of Patients With Major Bleedings in the Presence of Factor Xa Inhibitor Treatment
- Status
- COMPLETED
- Phase
- N/A
A Randomized Trial Evaluating a mRNA-VLP Vaccine's Immunogenicity and Safety for COVID-19
- Status
- COMPLETED
- Phase
- PHASE1
A Phase 1, Dose-escalation Study of [225Ac]-FPI-2068 in Adult Patients With Advanced Solid Tumours
- Status
- RECRUITING
- Phase
- PHASE1
Study to Assess the Pharmacokinetic Bioequivalence of Budesonide and Albuterol With an Alternate Propellant Compared to Current Propellant.
- Status
- COMPLETED
- Phase
- PHASE1
A Single and Multiple Ascending Dose Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD2389 in Healthy Participants
- Status
- COMPLETED
- Phase
- PHASE1
AZD3470 as Monotherapy or in Combination With Anticancer Agent(s) in Participants With Haematologic Malignancies.
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
AZD0486 as Monotherapy in B-cell Acute Lymphoblastic Leukaemia
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD6234 After Repeat Dose Administration in Participants Who Are Overweight or Obese
- Status
- COMPLETED
- Phase
- PHASE1
NIS Study Determining Prevalence of HER2-low in Metastatic Breast Cancer Patients
- Status
- COMPLETED
- Phase
- N/A
A Study of AZD3470, a PRMT5 Inhibitor, Given as Monotherapy and in Combination in Patients With MTAP Deficient Advanced/Metastatic Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Global Study of Volrustomig (MEDI5752) for Participants With Unresected Locally Advanced Head and Neck Squamous Cell Carcinoma Following Definitive Concurrent Chemoradiotherapy
- Status
- RECRUITING
- Phase
- PHASE3
HER2 TREAT Study: Retrospective Study to Estimate the Prevalence of HER2-low in Unresectable and/or Metastatic Breast Cancer Patients Who Progress on Anti-Cancer Therapy Identified as HER2-Negative From Patient Medical Records in The Gulf Cooperation Council
- Status
- COMPLETED
- Phase
- N/A